Podcasts about american patients first

Marti and Zach are back with some big healthcare legislative topics. First up we have the recently passed Right to Try Act. We discuss what it means for terminally ill patients and the future of the FDA. Next we have the Trump administrations proposal to lower out of pocket drug costs; "American Patients First." Ummm...we'll see how that goes.

Rene Thomas Folse, JD, Ph.D. is the host for this edition which reports on the following news stories. California and DOJ Join LA Whilstleblower Case Against Insys, President of Fresno Health Care Plan Pleads Guilty, Silicon Valley Orthopedist Sent to Prison, Fraud Claim May Close Sonoma West Medical Center, Three Running for California Insurance Commissioner, HHS "American Patients First" Plans to Lower Drug Prices, California Bill To Ban Patient Brokering and Reduce Fraud, FDA Approves First Non-Opioid - for Opioid Withdrawal, Managing Post-Operative Pain Without Opioids, Worldwide Facilities adds Workers' Compensation Products.

Creators of President Donald Trump’s blueprint to control drug prices, American Patients First, say it represents real reform. Critics see a pulled punch to the pharmaceutical industry. Mary Caffrey, the managing editor of The American Journal of Managed Care’s Evidence-Based series, spoke with Harvard healthcare economist Michael E. Chernew, PhD, who is the co-editor in chief of AJMC, to discuss elements of the Trump administration proposal to control drug prices. Chernew is also a former vice chair of the Medicare Payment Advisory Commission. Read more: Trump Offers Blueprint to Drive Down Prescription Drug Prices; Targets Rebates, "Middlemen": www.ajmc.com/newsroom/-trump-offers-blueprint-to-drive-down-prescription-drug-prices-targets-rebates-middlemen Azar Stumps for Plan to Hold Down Prescription Drug Costs: www.ajmc.com/focus-of-the-week/azar-stumps-for-plan-to-hold-down-prescription-drug-costs Trump Targets Drug Prices, Right-to-Try in State of the Union: www.ajmc.com/newsroom/trump-targets-drug-prices-righttotry-in-state-of-the-union ​​​​​​​Will Trump Take Steps to Rein in Drug Prices?: www.ajmc.com/focus-of-the-week/will-trump-take-steps-to-rein-in-drug-prices

One week ago, HHS Secretary Alex Azar joined President Donald Trump in the Rose Garden to announce his signature initiative: A long-awaited plan to lower drug prices. The secretary’s been on a tour to explain the plan — which has faced resistance from pharma and was panned by some Wall Street analysts — and POLITICO’s Dan Diamond joined Azar at HHS headquarters to review the latest developments. On this episode, Azar discusses where drug prices rank as an administration priority and how he wants taxpayers to judge success (starts at the 1:40 mark), why the plan doesn’t include importing drugs from Canada, an idea that Trump supported as a presidential candidate (5:15), why Azar wants to put drug prices in TV ads (9:00), whether he was prepared for the backlash to the plan (10:15), why he suggested that the media doesn’t want the drug plan to be perceived as successful (12:10), how Azar wants to combine Medicare Part B and Part D negotiations (13:10), and what Azar sees as a former pharma executive (16:45). Then stick around after the credits for a closing thought from Azar on his time at HHS (19:30). We'd appreciate your help: Please share PULSE CHECK and rate us on your favorite podcast app! Have questions, suggestions or feedback? Email ddiamond@politico.com. MENTIONED ON THE SHOW The Trump administration's "American Patients First" drug pricing plan: https://www.hhs.gov/sites/default/files/AmericanPatientsFirst.pdf Former Obama appointee Tim Gronniger, who steered CMS’ failed efforts to reform drug prices in 2016, joined POLITICO's podcast this week to share his perspective on the Trump plan: https://simplecast.com/s/7b2ddfbc The Community Oncology Alliance warned against the Trump plan: https://www.communityoncology.org/2018/05/16/may-16-coa-physician-survey-medicare-part-b-proposals-will-harm-patients-increase-costs-and-bureaucracy/ Vermont became the first state this week to permit drug imports from Canada: https://www.politico.com/story/2018/05/16/vermont-drug-imports-canada-546107 The FDA approved a biosimilar for an anemia drug this week: https://www.upi.com/FDA-approves-biosimilar-drug-for-anemia-treatment/4561526408086/ Azar appeared on the “Hugh Hewitt” radio show to discuss the drug plan this week: http://www.hughhewitt.com/hhs-secretary-alex-azar/